CCL5[Biotin], His & Avi, Human
CCL5[Biotin], His & Avi, Human

Immobilized CCL5[Biotin], His & Avi, Human, His Avi Tag at 1 μg/ml(100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Anti-CCL5 Antibody, hFc Tag with the EC50 of 5.2 ng/ml determined by ELISA.

CCL5[Biotin], His & Avi, Human

CCL5[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

CCL5[Biotin], His & Avi, Human

The CCR5 and the CCL5 ligand have been detected in some hematological malignancies, lymphomas, and a great number of solid tumors, but extensive studies on the role of the CCL5/CCR axis were performed only in a limited number of cancers.
Z04423
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
Avi His CCL5 (Ser24-Ser91)
Accession # P13501
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Immobilized CCL5[Biotin], His & Avi, Human at 1μg/ml (100μl/Well) on streptavidin (5μg/ml) precoated plate can bind Anti­CCL5 Antibody, hFc Tag. Test result was comparable to standard batch.
Expression System E.coli
Theoretical Molecular Weight 10.89 kDa
Apparent Molecular Weight The protein has a predicted MW of 10.89 kDa same as Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in 4mM HCI.
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in 4mM HCI.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • CCL5[Biotin], His & Avi, Human
    • CCL5[Biotin], His & Avi, Human

    Immobilized CCL5[Biotin], His & Avi, Human, His Avi Tag at 1 μg/ml(100 μl/well) on the streptavidin precoated plate(5 μg/ml). Dose response curve for Anti-CCL5 Antibody, hFc Tag with the EC50 of 5.2 ng/ml determined by ELISA.

  • CCL5[Biotin], His & Avi, Human
    • CCL5[Biotin], His & Avi, Human

    CCL5[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The CCR5 and the CCL5 ligand have been detected in some hematological malignancies, lymphomas, and a great number of solid tumors, but extensive studies on the role of the CCL5/CCR axis were performed only in a limited number of cancers.
Synonyms MuRantes; SIS-delta; Scya5; Ccl5; D17S136E; eoCP; RANTES; SCYA5; SISd; TCP228; CCL5

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.